Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.

Jevrić M, Matić IZ, Krivokuća A, Đorđić Crnogorac M, Besu I, Damjanović A, Branković-Magić M, Milovanović Z, Gavrilović D, Susnjar S, Kisić Tepavčević D, Stanojković T

Open source

DOI
10.1186/s12885-018-5255-z
Published
2019 Jan 15
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-018-5255-z,
  title = {Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.},
  author = {Jevrić M and Matić IZ and Krivokuća A and Đorđić Crnogorac M and Besu I and Damjanović A and Branković-Magić M and Milovanović Z and Gavrilović D and Susnjar S and Kisić Tepavčević D and Stanojković T},
  year = {2019},
  journal = {BMC cancer},
  doi = {10.1186/s12885-018-5255-z},
  url = {https://doi.org/10.1186/s12885-018-5255-z}
}

RIS

TY  - JOUR
TI  - Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.
AU  - Jevrić M
AU  - Matić IZ
AU  - Krivokuća A
AU  - Đorđić Crnogorac M
AU  - Besu I
AU  - Damjanović A
AU  - Branković-Magić M
AU  - Milovanović Z
AU  - Gavrilović D
AU  - Susnjar S
AU  - Kisić Tepavčević D
AU  - Stanojković T
PY  - 2019
JO  - BMC cancer
DO  - 10.1186/s12885-018-5255-z
UR  - https://doi.org/10.1186/s12885-018-5255-z
ER  - 

APA

M, J., IZ, M., A, K., M, Đ. C., I, B., A, D., M, B., Z, M., D, G., S, S., D, K. T., & T, S. (2019). Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.. BMC cancer. https://doi.org/10.1186/s12885-018-5255-z

Source records